Head-to-head comparison
Claya vs MyStart Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
$299/mo sema · $299/mo tirz · Verified June 2026
Marked down on: States-served list not disclosed — you must check at checkout
Desk Score
MyStart Health offers all-inclusive compounded semaglutide and tirzepatide at $299/month with a price-lock guarantee, same-day physician consultations, and 24/7 care team access.
$299/mo sema · $299/mo tirz · Verified July 2026
Marked down on: Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
FDAWarning letter issued to Matthew Stern, CEO MyStart Health LLC. in September 2025. See the FDA warning-letter database.
MyStart Health takes this head-to-head with the higher Desk Score, 70/100 (C) against 68/100 (C) for Claya. Claya still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Claya
68/100
C
MyStart Health
70/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Claya | MyStart Health |
|---|---|---|
| Semaglutide | $299/mo$299/mo (compounded) | $299/mo$299/mo (all doses, compounded) |
| Tirzepatide | $299/mo$299/mo (compounded) | $299/mo$299/mo (all doses, compounded) |
| Coverage | Not listed on Claya's site (checked June 2026) | Not listed on MyStart Health's site (checked July 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Compounded GLP-1 in injectable and oral-tablet forms with named clinicians. | Fastest compounded GLP-1 onboarding with a price lock. |
| Desk Score | 68/100C | 70/100C |
The verdict
Desk pick — MyStart HealthMyStart Health takes this head-to-head with the higher Desk Score, 70/100 (C) against 68/100 (C) for Claya. Claya still holds its ground where its strengths line up with yours.
Choose Claya if…
Compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
$299/mo sema · $299/mo tirz
Choose MyStart Health if…
Fastest compounded GLP-1 onboarding with a price lock.
$299/mo sema · $299/mo tirz
FDAWarning letter issued to Matthew Stern, CEO MyStart Health LLC. in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Claya · MyStart Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Claya vs CoreAge Rx
- CoreAge Rx vs MyStart Health
- Apex MD vs Claya
- Invigor Medical vs MyStart Health
- Claya vs Kova
- Apex MD vs MyStart Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.